ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2324

Leveraging ChatGPT for Real-World Systematic Lupus Erythematosus Data Curation from Electronic Health Records: A Feasibility Study

Lixia Yao, Liwam Gebru, Biruk Aweke, Jay Patel, Ernest Vina, David Fleece and Huanmei Wu, Temple University, Philadelphia, PA

Meeting: ACR Convergence 2023

Keywords: Administrative Data, American College of Rheumatology Criteria, antiphospholipid syndrome, classification criteria, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (2257–2325) SLE – Diagnosis, Manifestations, & Outcomes Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Epidemiologists, health services researchers, and health outcome investigators have begun utilizing real-world data (RWD) to gain valuable insights into disease patterns, treatment outcomes, and healthcare utilization and economics. Similarly, biopharmaceutical and medical device manufacturers utilize RWD to identify medical gaps, enhance patient care, and drive innovative therapeutic interventions. However, a significant portion (~80%) of essential clinical data is trapped in unstructured text within clinical notes, thereby remaining inaccessible in existing RWD for systemic lupus erythematosus (SLE).

Methods: To address this challenge, we leveraged the cutting-edge Natural Language Processing (NLP) model, ChatGPT 4.0, to analyze clinical notes to identify potential diagnosis of SLE. We evaluated:1) the adequacy of unstructured clinical notes in capturing essential clinical details (i.e., 22 clinical and immunologic variables) to support meeting the 2019 European League Against Rheumatism and American College of Rheumatology (EULAR/ACR) classification criteria for SLE; 2) the efficacy of the ChatGPT model in identifying those variables outlined in the EULAR/ACR criteria.

De-identified medical records were obtained from Temple University Health System’s EHR system (Epic), comprised patients aged 18 years or above, with at least at least one rheumatology visit and one ICD-10-CM code of M32.* (SLE) between 1/1/2012 and 5/31/2022. Using a Python script, we conducted an automatic search for various mentions of SLE in rheumatology visit notes. We then identified those with a positive anti-nuclear antibody (ANA) test. A thorough manual review of the rheumatology notes were conducted to determine if patients met the EULAR/ACR classification criteria. Subsequently, we employed ChatGPT 4.0 to extract the EULAR/ACR clinical variables.

Results: The initial Python search yielded 16,124 rheumatology notes from 445 unique patients. The follow-up search for positive ANA tests returned 1,147 rheumatology notes from 187 unique patients. The manual review by trained medical professionals revealed that 116 of the 187 patients met the EULAR/ACR criteria. There was a remarkably high level of agreement between the assessments made by ChatGPT 4.0 and those made by trained medical professionals (830 out of 880 clinical and immunologic variables across 40 randomly selected patients). Among the 50 annotations of disagreement (see Table 1), ChatGPT’s interpretations were found to be accurate in 29 cases. In some cases, the differentiation between acute cutaneous lupus vs. subacute cutaneous lupus was not clearly documented in the visit notes. In other cases, ChatGPT and human annotators had to infer the classification based on certain patient-reported symptoms like rash and photosensitivity.

Conclusion: Our findings confirm that unstructured clinical notes contain sufficient clinical details into SLE patient care, including 22 clinical and immunologic variables specified in the established classification criterion for SLE. Moreover, the utilization of state-of-the-art NLP techniques has significant promise in identifying those with SLE, potentially enhancing existing SLE research using RWD.

Supporting image 1

Figure 1. The overall study workflow

Supporting image 2

Table 1. Analysis of disagreements of annotations by medical professionals and ChatGPT


Disclosures: L. Yao: Merck/MSD, 3; L. Gebru: None; B. Aweke: None; J. Patel: None; E. Vina: None; D. Fleece: None; H. Wu: None.

To cite this abstract in AMA style:

Yao L, Gebru L, Aweke B, Patel J, Vina E, Fleece D, Wu H. Leveraging ChatGPT for Real-World Systematic Lupus Erythematosus Data Curation from Electronic Health Records: A Feasibility Study [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/leveraging-chatgpt-for-real-world-systematic-lupus-erythematosus-data-curation-from-electronic-health-records-a-feasibility-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/leveraging-chatgpt-for-real-world-systematic-lupus-erythematosus-data-curation-from-electronic-health-records-a-feasibility-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology